Greetings From the Editor of Clinical Thyroidology

Abstract

Clinical ThyroidologyVol. 34, No. 6 Greetings from the EditorFree AccessGreetings From the Editor of Clinical ThyroidologyAngela M. LeungAngela M. LeungSearch for more papers by this authorPublished Online:13 Jun 2022https://doi.org/10.1089/ct.2022;34.235-236AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail DEAR COLLEAGUESWelcome to the June issue of Clinical Thyroidology. This issue begins with a review by Dr. Kenneth Burman, who summarizes a study on suboptimal thyroid hormone replacement. Drs. Ricardo Correa and Ricardo Villela discuss a study done in patients with subclinical hyperthyroidism and cardiovascular outcomes, while Drs. Eijun Nishihara and Takashi Akamizu review the findings of a recent trial of rituximab use in young patients with Graves’ disease.On the topic of thyroid nodules and thyroid cancer, Dr. Benjamin Gigliotti comments on a survey study summarizing respondents’ viewpoints of the various risk-stratification systems available for estimating malignancy risk. Drs. N. Rhea Udyavar and Lilah Morris-Wiseman review a study reporting the associations between thyroid autoimmunity and incident thyroid cancer, while Dr. Ulla Feldt-Rasmussen describes a Danish study assessing the relationships between education, socioecononomic status, and thyroid cancer incidence.The potential need for levothyroxine replacement in patients who undergo hemithyroidectomy for low-risk papillary thyroid cancer is always an interesting clinical question. Drs. Erivelto Volpi and Leonardo Volpi summarize a retrospective trial that studied this question. This issue also features a review by Drs. Anupam Kotwal and Whitney Goldner, who examine a recent study reporting the characteristics of patients with BRAF V600E–mutant papillary thyroid cancer. Drs. Sara Duffus and Lindsay Bischoff discuss a study assessing the differences between Hürthle-cell and follicular thyroid carcinomas. Finally, Dr. Mayumi Endo summarizes the findings of a phase 3 trial studying treatment with selumetinib and radioactive iodine in patients with high-risk differentiated thyroid cancer.Clinical Thyroidology will continue to feature select highlighted abstracts presented at the American Thyroid Association's 2021 annual meeting. In this issue, Drs. Tiba Abdulwahid and Karen Selk share their case report entitled “A Rare Hideaway.” I invite all our readers to learn about the interesting clinical course they describe.As always, we invite our readers to join us through our social media channels. Through these other ways of communication, we discuss content featured in each month's issue and other issues related to hot topics in the clinical thyroid literature:Twitter:https://twitter.com/clinicalthyroid(@clinicalthyroid)Facebook:https://www.facebook.com/ThyroidAssociationLinkedIn:https://www.linkedin.com/company/american-thyroid-associationYoutube:https://www.youtube.com/user/thyroidorgAlso note that most of the material covered in Clinical Thyroidology is also translated into shorter lay summaries in our sister journal, Clinical Thyroidology for the Public [CTFP] (https://www.thyroid.org/patient-thyroid-information/ct-for-patients), that is edited by Dr. Alan Farwell and his team each month. The summaries in CTFP may be of use to patients and the public who are interested in reading more about recently published studies in the clinical thyroid literature.I hope that each issue provides helpful reviews, commentaries, editorials, and perspectives regarding how best to treat patients with thyroid disease. Guidelines for submitting Letters to the Editor and select Guest Editorials that cover timely and innovative aspects of clinical thyroid disease management may be found at https://home.liebertpub.com/publications/clinical-thyroidologyand174/623/for-authors.Thank you again for your interest in Clinical Thyroidology. Please feel free to send me any questions or comments at clinicalthyroidology@thyroid.org.Warmest regards,Angela M. Leung, MD, MScEditor-in-Chief, Clinical ThyroidologyFiguresReferencesRelatedDetails Volume 34Issue 6Jun 2022 Information© Copyright 2022, Mary Ann Liebert, Inc.To cite this article:Angela M. Leung.Greetings From the Editor of Clinical Thyroidology.Clinical Thyroidology.Jun 2022.235-236.http://doi.org/10.1089/ct.2022;34.235-236Published in Volume: 34 Issue 6: June 13, 2022PDF download